Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur MSD (SPM) (MFR control number DK-1577272925-2016006649) on 28-JUN-2016. Case received from a physician via HA on 23-JUN-2016 with reference number DK-DKMA-WBS-0003849. A 12-year-old female adolescent patient received GARDASIL, (batch number Lot UNK, Dose 1) via intramuscular route in November 2012, GARDASIL, (batch number lot UNK, Dose 2) via intramuscular route in February 2013, GARDASIL, (batch number Lot UNK, Dose 3) via intramuscular route in June 2013. Adverse Reaction: The patient experienced Tension-type headache, Nausea, Fatigue and 20% school attendance on an unknown date. The patient had a medical history of: -Headache, -Fatigue. History Around the Adverse Events: Disability in the form of 20% school attendance. Other vaccine: No. Other medicine: No. The patient''s outcome was reported as not recovered/not resolved.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166